Seres Therapeutics, Inc.
MCRB
$17.31
$0.613.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.71% | -36.29% | -47.07% | -75.94% | -60.67% |
| Total Receivables | -- | -93.76% | -62.78% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -49.89% | -66.67% | -3.00% | -27.78% | -32.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -29.35% | -67.38% | -60.00% | -77.95% | -65.98% |
|
|
|||||
| Total Current Assets | -29.35% | -67.38% | -60.00% | -77.95% | -65.98% |
| Net Property, Plant & Equipment | -12.81% | -28.63% | -28.35% | -14.43% | -27.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -15.85% | -83.07% | -83.04% | -88.43% | -52.21% |
| Total Assets | -19.73% | -55.30% | -51.89% | -61.01% | -51.39% |
|
|
|||||
| Total Accounts Payable | -79.68% | -54.25% | -58.46% | 12.03% | -7.86% |
| Total Accrued Expenses | -63.98% | -86.58% | -84.49% | -52.38% | -9.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.86% | 3.08% | 2.45% | 55.25% | 32.90% |
| Total Finance Division Other Current Liabilities | -85.42% | -73.62% | -68.67% | -73.48% | -31.22% |
| Total Other Current Liabilities | -85.42% | -73.62% | -68.67% | -73.48% | -31.22% |
| Total Current Liabilities | -65.40% | -71.43% | -68.19% | -58.22% | -18.17% |
|
|
|||||
| Total Current Liabilities | -65.40% | -71.43% | -68.19% | -58.22% | -18.17% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.65% | -22.77% | -22.10% | -9.48% | -18.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -57.37% | -97.99% | -98.05% | -98.35% | -95.16% |
| Total Liabilities | -35.55% | -72.88% | -71.64% | -68.76% | -59.56% |
|
|
|||||
| Common Stock & APIC | 1.46% | 3.53% | 3.89% | 6.27% | 7.00% |
| Retained Earnings | 0.56% | 8.18% | 7.16% | 0.01% | -2.72% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 82.69% | 137.84% | 184.48% | 130.73% | 258.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 82.69% | 137.84% | 184.48% | 130.73% | 258.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 82.69% | 137.84% | 184.48% | 130.73% | 258.16% |
|
|
|||||